CODEX Clinical Outcomes Databases Hidradenitis Suppurativa (HS) Fact Sheet CODEX Clinical Outcomes Databases Hidradenitis Suppurativa (HS) Explore Certara's CODEX Hidradenitis Suppurativa database ~43 studies with key efficiency and safety endpoints (HiSCR50,…Danielle PillsburySeptember 25, 2026
CODEX Clinical Outcomes Databases Chronic Heart Failure (CHF) Fact Sheet CODEX Clinical Outcomes Databases Chronic Heart Failure (CHF) Explore Certara's CODEX Chronic Heart Failure database ~200 studies with key efficiency and safety endpoints…CertaraSeptember 25, 2026
Marvin is now fully integrated as the unified drawing experience across Certara’s Discovery portfolio Announcement Marvin is now fully integrated as the unified drawing experience across Certara’s Discovery portfolio Marvin, Certara's chemical sketching tool, is now integrated across Design Hub, Compound Registration, Compliance Checker,…CertaraSeptember 25, 2026
Enable AI to Access your PK Data: What’s New in Integral 7.1 Webinar Enable AI to Access your PK Data: What’s New in Integral 7.1 CertaraSeptember 24, 2026
From Prediction to Decision Making: PBPK and QSP as Regulatory-Grade NAMs Publication From Prediction to Decision Making: PBPK and QSP as Regulatory-Grade NAMs New CPT review by Certara's Karen Rowland Yeo & Piet van der Graaf shows how…Danielle PillsburySeptember 23, 2026
From Excel to Enterprise: A Sponsor’s Journey to Modern Clinical Metadata Management Webinar From Excel to Enterprise: A Sponsor’s Journey to Modern Clinical Metadata Management Trevor MankusSeptember 23, 2026
Modeling effective doses of therapeutic antibodies targeting clustered surface receptors Publication Modeling effective doses of therapeutic antibodies targeting clustered surface receptors Discover how semi-mechanistic PK/receptor-occupancy modeling reveals that lower, subcutaneous doses, not maximum tolerated doses, optimize…Danielle PillsburySeptember 23, 2026
Model-Informed Strategies for ADC Development White Paper Model-Informed Strategies for ADC Development Explore how model informed drug development can help ADC developers optimize dosing, reduce uncertainty, strengthen…Danielle PillsburySeptember 22, 2026
Pistoia Alliance 2026 CSCS Conference Conference Pistoia Alliance 2026 CSCS Conference Zofia JordanSeptember 18, 2026
When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing Publication When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing Research shows that particle- and protein-based extracellular vesicle dosing are not interchangeable, supporting a multidimensional…CertaraSeptember 18, 2026